NHS National Generic Pharmaceuticals Wave 15a

Concepts

• pharmaceutical products
• runcorn
• nhs national generic pharmaceuticals wave 15a
• 15a
• nhs national generic pharmaceuticals wave
• nhs national generic pharmaceuticals - wave 15a
• nhs
• national
• pharmaceuticals
• wave

Location

Description

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 15a. Offer reference number: CM/PHG/23/5697. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5697/01 - Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months) CM/PHG/23/5697/02 - Hospital Only Products: DNW & DLN: 01/02/2025 to 31/01/2027 (24 months) CM/PHG/23/5697/03 - Hospital Only Products (Housekeeping): DLS & DNE: 01/02/2025 to 31/05/2026 (16 months) DCE & DSW: 01/02/2025 to 30/09/2025 (8 months)

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.doc Document No. 01 - Invitation to offer covering letter Document No. 01 - Invitation to offer covering letter.docx Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.pdf Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023) Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).docx Document No. 06 - Form of offer Document No. 06 - Form of offer.doc Document No. 05a (iii) Product Listing and Usage - Hospital Only (DNW & DLN) CM_PHG_23_5697_02 Document No. 05a (iii) Product Listing and Usage - Hospital Only (DNW & DLN) CM_PHG_23_5697_02.xlsx Document No. 07a - Quality control technical sheet Document No. 07a - Quality control technical sheet.doc Document No. 05a (i) - Product Listing and Usage - Orals (plus non-parenteral) Products (CESW, LSNE & NWLN) CM_PHG_23_5697_01 Document No. 05a (i) - Product Listing and Usage - Orals (plus non-parenteral) Products (CESW, LSNE & NWLN) CM_PHG_23_5697_01.xlsx Document No. 05a (v) - Product Listing & Usage - Hospital Only (Housekeeping) Products (DCE, DSW, DLS & DNE) CM_PHG_23_5697_03 Document No. 05a (v) - Product Listing & Usage - Hospital Only (Housekeeping) Products (DCE, DSW, DLS & DNE) CM_PHG_23_5697_03.xlsx Document No. 00 - Read Me First Document Document No. 00 - Read Me First Document.docx Document No. 08 - Confidential information schedule Document No. 08 - Confidential information schedule.xls Document No. 09 - Stability Data Requirements Document No. 09 - Stability Data Requirements.xlsx Document No. 05a (ii) (iv) and (vi) CM_PHG_23_5697 Selectt Application Document No. 05a (ii) (iv) and (vi) CM_PHG_23_5697 Selectt Application.docx Document No. 02 - Terms of offer Document No. 02 - Terms of offer.doc Document No. 05b - Selectt offer schedule instructions Document No. 05b - Selectt offer schedule instructions.docx Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.docx